Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
104.80    -2.40 (-2.24%)
Bid:
104.80
Ask:
106.00
Spread: 1.20 (1.145%)
Market Cap: £440.53m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Update

8 Dec 2011 07:00

RNS Number : 5528T
PZ CUSSONS PLC
08 December 2011
 



8 December 2011

PZ Cussons Plc

(the "Group")

 

TRADING UPDATE

 

PZ Cussons Plc announces its trading update in respect of the half year to 30 November 2011.

 

First half trading

 

The Group's businesses in its core markets of the UK, Indonesia and Nigeria have achieved continued momentum with good revenue growth in the period, however a continued high level of raw material costs and adverse exchange rate movement have impacted margins. In addition, trading conditions in Australia, and in the smaller markets of Greece, Thailand and the Middle East, have been challenging. As a result profit overall for the period has been below expectations.

 

The financial position of the Group is strong with negligible net borrowings at the end of the period.

 

Trading - Update

 

Europe

 

The UK washing and bathing division has experienced good revenue growth despite worsening consumer confidence although continued high levels of promotional activity in the retailers and high raw material prices have put some pressure on margins. New product launches in the period have been well received and include Carex 'Protect Plus' with a new technology that kills bacteria for up to two hours after use.

 

The newly formed beauty division, created following the acquisition of The Sanctuary and more recently St Tropez, has performed well with an increase in revenue and profit despite tougher trading conditions in all UK distribution channels. New product launches have been successful and include the Charles Worthington 'Salon at home' range which has experienced good sales rates since launch in September.

 

Performance in Poland has been robust with revenue and profit ahead of the prior period. Trading conditions in Greece have been difficult as a result of the domestic economic situation.

 

Asia

 

Revenue and profit in Australia are lower than the previous period due to competitive trading conditions in the retailers and high raw material costs.

 

Continued positive momentum in Indonesia has delivered another period of revenue and profit growth largely from the market leading Cussons Baby range.

 

Trading in the Middle East has been affected by social and political unrest in those territories. Supply from Thailand was affected by the recent floods although the situation is now returning to near normal.

 

Africa

 

In Nigeria, revenue growth in all business units has been strong as economic and political stability returns to the country following elections earlier this year. Continued high levels of raw material costs together with a weaker naira have, however, impacted margins in the period. The effect of higher cost of stock together with longer port clearance times have also lead to higher inventory levels as the territory enters peak trading season.

 

Construction of the palm oil refinery with Wilmar in Nigeria is on schedule with completion due by the end of the 2012 calendar year.

 

Performance in Ghana and Kenya has been robust and ahead of the prior period.

 

Directors

 

As announced last month, Helen Owers and Ngozi Edozien will join the board as non-executive directors on 1 January 2012.

 

Full year outlook

 

The trading environment will continue to be difficult given increasing pressures on consumer spending power in all markets, continued high levels of promotional activity in developed markets and the UK in particular, and ongoing high level of input costs.

 

Our focus remains on driving profitable growth for the year through continued brand renovation and margin improvement in all territories.

 

Our strong financial position will enable us to invest in attractive medium term growth opportunities in our core markets in Europe, Asia and Africa.

 

Interim Announcement

 

Interim results for the half year to 30 November 2011 will be announced on Tuesday 24th January 2012.

 

An analysts' presentation will be given at 9:30am on that day at the offices of Panmure Gordon, Moorgate Hall, 155 Moorgate, London EC2M 6XB.

 

For further information contact:

 

PZ Cussons Plc Tel: 0161 435 1016

Brandon Leigh - Finance Director

 

MHP Communications Tel: 020 3128 8100

John Olsen / James White

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGGAAPUPGGAM
Date   Source Headline
20th Dec 20214:35 pmRNSDirector/PDMR Shareholding
9th Dec 20219:38 amRNSNotice of Interim Results
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.